Kent Holtorf, MD - LDN should be considered a first-line therapy for CFS/FM (2019 Conference) (LDN, low dose naltrexone)

Cory Tichauer, ND - LDN and Lyme Disease I  (2017 Conference) (LDN, low dose naltrexone)

Dr Cory Tichauer shares his presentation on LDN and Lyme Disease at The LDN 2017 Conference.

Dr Tichauer begins by highlighting that Chronic Lyme Disease has many overlapping symptoms from PTLS but can also involve other organ dysfunction due to active infections still causing tissue damage.

Armin Schwarzbach, MD, PhD - Modern tests for diagnosing Lyme Disease (2017 Conference) (LDN, low dose naltrexone)

Lyme disease is a bacterial infection that can be spread to humans by infected ticks. It's usually easier to treat if it's diagnosed early. In this presentation Dr Schwarzbach talks about modern tests for Lyme disease and how crucial it is to get the diagnosis right.

Darin Ingels, ND - Lyme Disease (2017 Conference) (LDN, low dose naltrexone)

In this presentation Dr Ingels adopts a scientific approach of explaining Lyme Disease, thus the audience can thoroughly understand why specific approaches and treatments work and others do not.

It is commonly misdiagnosed or not diagnosed at all. Lyme disease testing is inadequate and false negative tests are commonplace.

Kent Holtorf, MD - Immune Dysfunction and Chronic Lyme Disease (2017 Conference) (LDN, low

Dr Kent Holtorf deals specifically with Lyme Disease in this presentation and its impact upon the immune system, explaining the process he uses to test for and diagnose Lyme. 

Dr Yusuf Saleeby - 19th Feb 2020 (LDN, low dose naltrexone) from LDN Research Trust on Vimeo.

Dr Yusuf Saleeby shares his Low Dose Naltrexone (LDN) experience on the LDN Radio Show with Linda Elsegood.